This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Breathe BioMedical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

William Dawes

Chief executive officer

CA$987.4k

Total compensation

CEO salary percentage	49.02%
CEO tenure	1yr
CEO ownership	n/a
Management average tenure	1.2yrs
Board average tenure	3.5yrs

Recent management updates

No updates

Recent updates

No updates

CEO Compensation Analysis

How has William Dawes's remuneration changed compared to Breathe BioMedical's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	-CA$11m
Dec 31 2023	CA$987k	CA$484k	-CA$8m

Compensation vs Market: William's total compensation ($USD733.73K) is about average for companies of similar size in the US market ($USD667.11K).

Compensation vs Earnings: Insufficient data to compare William's compensation with company performance.

CEO

William Dawes (52 yo)

1yr

Tenure

CA$987,426

Compensation

Mr. William C. Dawes Jr. serves as Chief Executive Officer at Breathe BioMedical Inc. since August 14, 2023. He served as Executive Vice President of LikeMinds, Inc./DE until 2022. He was responsible for O...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
William Dawes	Chief Executive Officer	1yr	CA$987.43k	no data
Peili Miao	Chief Financial Officer	less than a year	CA$31.67k	no data
Christopher Purves	Chief Technology Officer	16.8yrs	CA$205.65k	no data
Sandra Veenstra	Chief Regulatory Officer	1.2yrs	CA$177.30k	no data
Rachel Brem	Chief Medical Officer & Director	less than a year	no data	no data
Chris Purves	Chief Technology Officer	no data	no data	no data
Michael Tripp	Vice President of Corporate Development and General Counsel	11.8yrs	no data	no data
Irene Gaudet	Vice President of Marketing & Sales	11.8yrs	no data	no data
Sandra Veenstra	Chief Regulatory Officer	1.6yrs	no data	no data
Joanne Young	Vice President of Clinical	1.2yrs	no data	no data

1.2yrs

Average Tenure

48.5yo

Average Age

Experienced Management: BRTH's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Rachel Brem	Chief Medical Officer & Director	less than a year	no data	no data
Peter Savas	Independent Director	4.3yrs	CA$89.66k	no data
Gaetan Thomas	Independent Director	2.6yrs	CA$62.75k	no data
Telfer Hanson	Vice Chairman of the Board	1.2yrs	CA$678.60k	no data
Jean Nadeau	Board Chair	no data	no data	no data
Peter Savas	Director	no data	no data	no data
Don Hardison	Director	no data	no data	no data
Romeo Goguen	Director	no data	no data	no data
Rahul Dhanda	Director	no data	no data	no data
Thomas Gaetan	Director	no data	no data	no data
Romeo Goguen	Director	8.6yrs	CA$62.75k	no data
Jean Nadeau	Independent Chairman of the Board	10.8yrs	CA$110.86k	no data

3.5yrs

Average Tenure

64.5yo

Average Age

Experienced Board: BRTH's board of directors are considered experienced (3.5 years average tenure).

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/08/27 19:50
End of Day Share Price	2024/08/27 00:00
Earnings	2024/03/31
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Breathe BioMedical Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.